Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Shares withheld for taxes EVP Prod Dev & Med Aff & CMO gave up 27,224 shares (to pay taxes)
  2. 4 Planned sale CSO/EVP Disc & Trans Research sold 96,986 shares at $35.00 ($3,394,510)
  3. 4 Planned sale EVP & General Counsel sold 50,000 shares at $34.13 ($1,706,500)
  4. 4 Open-market sale Director sold 30,000 shares at $34.00 ($1,020,000)
  5. 4 Gift President and CEO gave 46,000 shares (gift)
  6. 4 Planned sale CSO/EVP Disc & Trans Research sold 1,162 shares at $31.40 ($36,487)
  7. 4 Planned sale EVP & General Counsel sold 25,000 shares at $28.39 ($709,750)
  8. 4 Shares withheld for taxes EVP, Commercial gave up 96,111 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 463,702 shares (to pay taxes)
  10. 4 Planned sale EVP & General Counsel sold 25,000 shares at $26.38 ($659,500)
  11. 4 Planned sale EVP, General Counsel & Sec sold 20,000 shares at $25.79 ($515,800)
  12. 4 Open-market sale Director sold 8,250 shares at $26.56 ($219,120)
  13. 4 Other disposition Director disposed of 4,682 shares (other)
  14. 4 Open-market sale CSO/EVP Disc & Trans Research sold 20,883 shares at $27.06 ($565,094)
  15. 4 Open-market sale Director sold 33,725 shares at $26.89 ($906,865)
  16. 4 Planned sale CSO/EVP Disc & Trans Research sold 95,000 shares at $25.00 ($2,375,000)
  17. 4 Planned sale EVP, Commercial sold 14,000 shares at $25.50 ($357,000)
  18. 4 Planned sale EVP, General Counsel & Sec sold 80,000 shares at $25.97 ($2,077,600)
  19. 4 Open-market sale EVP and CFO sold 125,000 shares at $27.19 ($3,398,750)
  20. 4 Planned sale Director sold 8,287 shares at $22.00 ($182,314)

Page 7 of 73 · 1,458 filings